Gary G. Deng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gary G. Deng has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Alex Wu
Knuppe Molecular Urology Laboratory, Department of Urology, School of Medicine, University of California, San Francisco, CA, USA
1 shared publication Anthony Johns
Cardiovascular Research, Berlex Biosciences, Richmond, California
1 shared publication- Ching-Shwun Lin
Knuppe Molecular Urology Laboratory, Department of Urology, School of Medicine, University of California, San Francisco, CA, USA
1 shared publication - David R. Greaves
Sir William Dunn School of Pathology, University of Oxford, United Kingdom
1 shared publication - Fei Tian
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
1 shared publication - Guifang Wang
Knuppe Molecular Urology Laboratory, Department of Urology, School of Medicine, University of California, San Francisco, CA, USA
1 shared publication
Latest Publications
- 1 April 2015
- Published by Elsevier in European Urology
- Vol. 67 (4) , 716-726
Novel Therapeutic Approach for Neurogenic Erectile Dysfunction: Effect of Neurotrophic Tyrosine Kinase Receptor Type 1 Monoclonal Antibody
- 1 April 2015
- Published by Elsevier in European Urology
- Vol. 67 (4) , 716-726
Novel Therapeutic Approach for Neurogenic Erectile Dysfunction: Effect of Neurotrophic Tyrosine Kinase Receptor Type 1 Monoclonal Antibody
- 22 November 2007
- Published by Springer Nature in Gene Therapy
- Vol. 15 (3) , 224-232
Overexpression of PAI-1 prevents the development of abdominal aortic aneurysm in mice
Vessel wall inflammation and matrix destruction are critical to abdominal aortic aneurysm (AAA) formation and rupture. We have previously shown that urokinase plasminogen activator (uPA) is highly expressed in experimental AAA and is essential for AAA formation and expansion. In this study, we examined the effects of overexpression of a natural inhibitor of uPA, plasminogen activator inhibitor-1 (PAI-1), on the development of angiotensin (Ang) II-induced AAA in ApoE-deficient (ApoE−/−) mice. Mice were treated with recombinant adenovirus containing either the human PAI-1 gene (Ad5.CMV.PAI-1) or the luciferase gene (Ad5.CMV.Luc) delivered either locally by intra-adventitial injection or systemically by tail vein injection. Our results show that local delivery of the PAI-1 gene completely prevented AAA formation (0 vs 55.6% in Ad5.CMV.Luc controls, PP=0.125). Local delivery of the PAI-1 gene 2 weeks after Ang II infusion prevented further expansion of small aneurysms, but had no significant effect on the progression of larger aneurysms. These data suggest that local PAI-1 gene transfer could be used to stabilize small AAA and reduce the rate of expansion and risk of rupture.
- 22 November 2007
- Published by Springer Nature in Gene Therapy
- Vol. 15 (3) , 224-232
Overexpression of PAI-1 prevents the development of abdominal aortic aneurysm in mice
Vessel wall inflammation and matrix destruction are critical to abdominal aortic aneurysm (AAA) formation and rupture. We have previously shown that urokinase plasminogen activator (uPA) is highly expressed in experimental AAA and is essential for AAA formation and expansion. In this study, we examined the effects of overexpression of a natural inhibitor of uPA, plasminogen activator inhibitor-1 (PAI-1), on the development of angiotensin (Ang) II-induced AAA in ApoE-deficient (ApoE−/−) mice. Mice were treated with recombinant adenovirus containing either the human PAI-1 gene (Ad5.CMV.PAI-1) or the luciferase gene (Ad5.CMV.Luc) delivered either locally by intra-adventitial injection or systemically by tail vein injection. Our results show that local delivery of the PAI-1 gene completely prevented AAA formation (0 vs 55.6% in Ad5.CMV.Luc controls, PP=0.125). Local delivery of the PAI-1 gene 2 weeks after Ang II infusion prevented further expansion of small aneurysms, but had no significant effect on the progression of larger aneurysms. These data suggest that local PAI-1 gene transfer could be used to stabilize small AAA and reduce the rate of expansion and risk of rupture.
- 30 November 2004
- Published by Wiley in Journal of Cellular Physiology
- Vol. 204 (1) , 73-82
Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice
The urokinase plasminogen activator receptor (uPAR) regulates macrophage adhesion and migration by binding directly to matrix proteins and signaling through integrin complexes. In this study, we examined the role of uPAR on macrophage infiltration into the vascular wall. Stable murine macrophage (Raw264.7) cell lines expressing high levels of human uPAR, human urokinase plasminogen activator (uPA), or both were established using expression vectors driven by the human CD68 promoter. Stimulation with human uPA specifically induced phosphorylation of early response regulated kinase (ERK) in cells expressing human uPAR but not in sham transfected cells. The human uPAR expressing Raw264.7 cells showed increased adhesion to both human uPA and vitronectin (Vn). Raw264.7 cells expressing human uPAR or both human uPAR and uPA, but not uPA alone, were detected in the aortic wall of ApoE−/− mice, and no cells were detected in that of age‐matched C57BL/6J mice after intravenous infusion of the cells. Blocking of Mac‐1/ICAM‐1 interaction by anti‐αM antibody (M1/70) significantly reduced the infiltration of huPAR‐expressing Raw264.1 cells into aorta of ApoE−/− mice. Treatment of C57BL/6J mice with angiotensin II resulted in infiltration of Raw264.7 cells expressing human uPAR. These data demonstrate that uPAR plays a key role in promoting macrophage infiltration into the arterial wall of ApoE−/− mice.
- 30 November 2004
- Published by Wiley in Journal of Cellular Physiology
- Vol. 204 (1) , 73-82
Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice
The urokinase plasminogen activator receptor (uPAR) regulates macrophage adhesion and migration by binding directly to matrix proteins and signaling through integrin complexes. In this study, we examined the role of uPAR on macrophage infiltration into the vascular wall. Stable murine macrophage (Raw264.7) cell lines expressing high levels of human uPAR, human urokinase plasminogen activator (uPA), or both were established using expression vectors driven by the human CD68 promoter. Stimulation with human uPA specifically induced phosphorylation of early response regulated kinase (ERK) in cells expressing human uPAR but not in sham transfected cells. The human uPAR expressing Raw264.7 cells showed increased adhesion to both human uPA and vitronectin (Vn). Raw264.7 cells expressing human uPAR or both human uPAR and uPA, but not uPA alone, were detected in the aortic wall of ApoE−/− mice, and no cells were detected in that of age‐matched C57BL/6J mice after intravenous infusion of the cells. Blocking of Mac‐1/ICAM‐1 interaction by anti‐αM antibody (M1/70) significantly reduced the infiltration of huPAR‐expressing Raw264.1 cells into aorta of ApoE−/− mice. Treatment of C57BL/6J mice with angiotensin II resulted in infiltration of Raw264.7 cells expressing human uPAR. These data demonstrate that uPAR plays a key role in promoting macrophage infiltration into the arterial wall of ApoE−/− mice.